nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP2B6—Sorafenib—liver cancer	0.128	0.216	CbGbCtD
Modafinil—CYP3A5—Sorafenib—liver cancer	0.1	0.17	CbGbCtD
Modafinil—CYP2C19—Sorafenib—liver cancer	0.081	0.137	CbGbCtD
Modafinil—CYP2B6—Doxorubicin—liver cancer	0.0774	0.131	CbGbCtD
Modafinil—CYP1A2—Sorafenib—liver cancer	0.0748	0.126	CbGbCtD
Modafinil—CYP2C9—Sorafenib—liver cancer	0.0674	0.114	CbGbCtD
Modafinil—CYP3A4—Sorafenib—liver cancer	0.0392	0.0662	CbGbCtD
Modafinil—CYP3A4—Doxorubicin—liver cancer	0.0238	0.0402	CbGbCtD
Modafinil—Photosensitivity—Epirubicin—liver cancer	0.000759	0.00311	CcSEcCtD
Modafinil—Constipation—Sorafenib—liver cancer	0.000758	0.0031	CcSEcCtD
Modafinil—Pain—Sorafenib—liver cancer	0.000758	0.0031	CcSEcCtD
Modafinil—Hypertonia—Doxorubicin—liver cancer	0.000745	0.00305	CcSEcCtD
Modafinil—Eczema—Epirubicin—liver cancer	0.000742	0.00304	CcSEcCtD
Modafinil—Abnormal vision—Doxorubicin—liver cancer	0.000741	0.00303	CcSEcCtD
Modafinil—Eye pain—Epirubicin—liver cancer	0.000739	0.00302	CcSEcCtD
Modafinil—Mental disability—Doxorubicin—liver cancer	0.000737	0.00302	CcSEcCtD
Modafinil—Gastrointestinal pain—Sorafenib—liver cancer	0.000725	0.00297	CcSEcCtD
Modafinil—Increased appetite—Epirubicin—liver cancer	0.00071	0.00291	CcSEcCtD
Modafinil—Hepatic function abnormal—Doxorubicin—liver cancer	0.000706	0.00289	CcSEcCtD
Modafinil—Urticaria—Sorafenib—liver cancer	0.000704	0.00288	CcSEcCtD
Modafinil—Photosensitivity—Doxorubicin—liver cancer	0.000703	0.00288	CcSEcCtD
Modafinil—Body temperature increased—Sorafenib—liver cancer	0.000701	0.00287	CcSEcCtD
Modafinil—Abdominal pain—Sorafenib—liver cancer	0.000701	0.00287	CcSEcCtD
Modafinil—Anaphylactoid reaction—Epirubicin—liver cancer	0.000689	0.00282	CcSEcCtD
Modafinil—Eczema—Doxorubicin—liver cancer	0.000686	0.00281	CcSEcCtD
Modafinil—Eye pain—Doxorubicin—liver cancer	0.000683	0.0028	CcSEcCtD
Modafinil—Osteoarthritis—Epirubicin—liver cancer	0.000667	0.00273	CcSEcCtD
Modafinil—Increased appetite—Doxorubicin—liver cancer	0.000657	0.00269	CcSEcCtD
Modafinil—Migraine—Epirubicin—liver cancer	0.000656	0.00269	CcSEcCtD
Modafinil—Affect lability—Epirubicin—liver cancer	0.000656	0.00269	CcSEcCtD
Modafinil—Hypersensitivity—Sorafenib—liver cancer	0.000653	0.00267	CcSEcCtD
Modafinil—Bifonazole—CYP2E1—liver cancer	0.000651	0.16	CrCbGaD
Modafinil—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000637	0.00261	CcSEcCtD
Modafinil—Asthenia—Sorafenib—liver cancer	0.000636	0.0026	CcSEcCtD
Modafinil—Cardiac arrest—Epirubicin—liver cancer	0.000634	0.0026	CcSEcCtD
Modafinil—Mood swings—Epirubicin—liver cancer	0.000632	0.00259	CcSEcCtD
Modafinil—Pruritus—Sorafenib—liver cancer	0.000627	0.00257	CcSEcCtD
Modafinil—Ataxia—Epirubicin—liver cancer	0.000627	0.00257	CcSEcCtD
Modafinil—Osteoarthritis—Doxorubicin—liver cancer	0.000617	0.00253	CcSEcCtD
Modafinil—Dry skin—Epirubicin—liver cancer	0.000611	0.0025	CcSEcCtD
Modafinil—Abdominal pain upper—Epirubicin—liver cancer	0.000609	0.00249	CcSEcCtD
Modafinil—Affect lability—Doxorubicin—liver cancer	0.000607	0.00249	CcSEcCtD
Modafinil—Migraine—Doxorubicin—liver cancer	0.000607	0.00249	CcSEcCtD
Modafinil—Diarrhoea—Sorafenib—liver cancer	0.000607	0.00248	CcSEcCtD
Modafinil—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.0006	0.00246	CcSEcCtD
Modafinil—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.0006	0.00246	CcSEcCtD
Modafinil—Muscular weakness—Epirubicin—liver cancer	0.000588	0.00241	CcSEcCtD
Modafinil—Cardiac arrest—Doxorubicin—liver cancer	0.000587	0.0024	CcSEcCtD
Modafinil—Dizziness—Sorafenib—liver cancer	0.000586	0.0024	CcSEcCtD
Modafinil—Mood swings—Doxorubicin—liver cancer	0.000584	0.00239	CcSEcCtD
Modafinil—Ataxia—Doxorubicin—liver cancer	0.00058	0.00237	CcSEcCtD
Modafinil—Influenza—Epirubicin—liver cancer	0.000576	0.00236	CcSEcCtD
Modafinil—Asthma—Epirubicin—liver cancer	0.000576	0.00236	CcSEcCtD
Modafinil—Eosinophilia—Epirubicin—liver cancer	0.000571	0.00234	CcSEcCtD
Modafinil—Dry skin—Doxorubicin—liver cancer	0.000565	0.00231	CcSEcCtD
Modafinil—Vomiting—Sorafenib—liver cancer	0.000564	0.00231	CcSEcCtD
Modafinil—Abdominal pain upper—Doxorubicin—liver cancer	0.000563	0.00231	CcSEcCtD
Modafinil—Rash—Sorafenib—liver cancer	0.000559	0.00229	CcSEcCtD
Modafinil—Dermatitis—Sorafenib—liver cancer	0.000559	0.00229	CcSEcCtD
Modafinil—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000556	0.00227	CcSEcCtD
Modafinil—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000556	0.00227	CcSEcCtD
Modafinil—Headache—Sorafenib—liver cancer	0.000555	0.00227	CcSEcCtD
Modafinil—Bronchitis—Epirubicin—liver cancer	0.000554	0.00227	CcSEcCtD
Modafinil—Pancytopenia—Epirubicin—liver cancer	0.000547	0.00224	CcSEcCtD
Modafinil—Muscular weakness—Doxorubicin—liver cancer	0.000544	0.00223	CcSEcCtD
Modafinil—Asthma—Doxorubicin—liver cancer	0.000533	0.00218	CcSEcCtD
Modafinil—Influenza—Doxorubicin—liver cancer	0.000533	0.00218	CcSEcCtD
Modafinil—Pollakiuria—Epirubicin—liver cancer	0.000532	0.00218	CcSEcCtD
Modafinil—Eosinophilia—Doxorubicin—liver cancer	0.000528	0.00216	CcSEcCtD
Modafinil—Nausea—Sorafenib—liver cancer	0.000527	0.00216	CcSEcCtD
Modafinil—Photosensitivity reaction—Epirubicin—liver cancer	0.000526	0.00215	CcSEcCtD
Modafinil—Weight increased—Epirubicin—liver cancer	0.000524	0.00215	CcSEcCtD
Modafinil—Weight decreased—Epirubicin—liver cancer	0.000521	0.00213	CcSEcCtD
Modafinil—Hyperglycaemia—Epirubicin—liver cancer	0.00052	0.00213	CcSEcCtD
Modafinil—Pneumonia—Epirubicin—liver cancer	0.000517	0.00212	CcSEcCtD
Modafinil—Warfarin—CYP1A1—liver cancer	0.000515	0.127	CrCbGaD
Modafinil—Drowsiness—Epirubicin—liver cancer	0.000514	0.0021	CcSEcCtD
Modafinil—Bronchitis—Doxorubicin—liver cancer	0.000513	0.0021	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000509	0.00209	CcSEcCtD
Modafinil—Pancytopenia—Doxorubicin—liver cancer	0.000506	0.00207	CcSEcCtD
Modafinil—Stomatitis—Epirubicin—liver cancer	0.000501	0.00205	CcSEcCtD
Modafinil—Conjunctivitis—Epirubicin—liver cancer	0.000499	0.00204	CcSEcCtD
Modafinil—Urinary tract infection—Epirubicin—liver cancer	0.000499	0.00204	CcSEcCtD
Modafinil—Sweating—Epirubicin—liver cancer	0.000493	0.00202	CcSEcCtD
Modafinil—Pollakiuria—Doxorubicin—liver cancer	0.000493	0.00202	CcSEcCtD
Modafinil—Haematuria—Epirubicin—liver cancer	0.00049	0.00201	CcSEcCtD
Modafinil—Photosensitivity reaction—Doxorubicin—liver cancer	0.000487	0.00199	CcSEcCtD
Modafinil—Weight increased—Doxorubicin—liver cancer	0.000485	0.00199	CcSEcCtD
Modafinil—Epistaxis—Epirubicin—liver cancer	0.000485	0.00198	CcSEcCtD
Modafinil—Weight decreased—Doxorubicin—liver cancer	0.000482	0.00197	CcSEcCtD
Modafinil—Sinusitis—Epirubicin—liver cancer	0.000482	0.00197	CcSEcCtD
Modafinil—Hyperglycaemia—Doxorubicin—liver cancer	0.000481	0.00197	CcSEcCtD
Modafinil—Agranulocytosis—Epirubicin—liver cancer	0.000479	0.00196	CcSEcCtD
Modafinil—Pneumonia—Doxorubicin—liver cancer	0.000478	0.00196	CcSEcCtD
Modafinil—Drowsiness—Doxorubicin—liver cancer	0.000475	0.00195	CcSEcCtD
Modafinil—Fosphenytoin—ALB—liver cancer	0.000472	0.116	CrCbGaD
Modafinil—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000471	0.00193	CcSEcCtD
Modafinil—Bradycardia—Epirubicin—liver cancer	0.00047	0.00192	CcSEcCtD
Modafinil—Stomatitis—Doxorubicin—liver cancer	0.000463	0.0019	CcSEcCtD
Modafinil—Rhinitis—Epirubicin—liver cancer	0.000462	0.00189	CcSEcCtD
Modafinil—Conjunctivitis—Doxorubicin—liver cancer	0.000462	0.00189	CcSEcCtD
Modafinil—Urinary tract infection—Doxorubicin—liver cancer	0.000462	0.00189	CcSEcCtD
Modafinil—Pharyngitis—Epirubicin—liver cancer	0.000458	0.00187	CcSEcCtD
Modafinil—Sweating—Doxorubicin—liver cancer	0.000456	0.00187	CcSEcCtD
Modafinil—Urinary tract disorder—Epirubicin—liver cancer	0.000455	0.00186	CcSEcCtD
Modafinil—Oedema peripheral—Epirubicin—liver cancer	0.000454	0.00186	CcSEcCtD
Modafinil—Haematuria—Doxorubicin—liver cancer	0.000453	0.00186	CcSEcCtD
Modafinil—Connective tissue disorder—Epirubicin—liver cancer	0.000453	0.00186	CcSEcCtD
Modafinil—Urethral disorder—Epirubicin—liver cancer	0.000452	0.00185	CcSEcCtD
Modafinil—Epistaxis—Doxorubicin—liver cancer	0.000448	0.00184	CcSEcCtD
Modafinil—Sinusitis—Doxorubicin—liver cancer	0.000446	0.00183	CcSEcCtD
Modafinil—Visual impairment—Epirubicin—liver cancer	0.000444	0.00182	CcSEcCtD
Modafinil—Agranulocytosis—Doxorubicin—liver cancer	0.000444	0.00182	CcSEcCtD
Modafinil—Erythema multiforme—Epirubicin—liver cancer	0.000436	0.00179	CcSEcCtD
Modafinil—Bradycardia—Doxorubicin—liver cancer	0.000434	0.00178	CcSEcCtD
Modafinil—Cardiac disorder—Epirubicin—liver cancer	0.000428	0.00175	CcSEcCtD
Modafinil—Rhinitis—Doxorubicin—liver cancer	0.000428	0.00175	CcSEcCtD
Modafinil—Pharyngitis—Doxorubicin—liver cancer	0.000424	0.00173	CcSEcCtD
Modafinil—Urinary tract disorder—Doxorubicin—liver cancer	0.000421	0.00173	CcSEcCtD
Modafinil—Oedema peripheral—Doxorubicin—liver cancer	0.00042	0.00172	CcSEcCtD
Modafinil—Connective tissue disorder—Doxorubicin—liver cancer	0.000419	0.00172	CcSEcCtD
Modafinil—Angiopathy—Epirubicin—liver cancer	0.000418	0.00171	CcSEcCtD
Modafinil—Urethral disorder—Doxorubicin—liver cancer	0.000418	0.00171	CcSEcCtD
Modafinil—Immune system disorder—Epirubicin—liver cancer	0.000417	0.00171	CcSEcCtD
Modafinil—Mediastinal disorder—Epirubicin—liver cancer	0.000416	0.0017	CcSEcCtD
Modafinil—Chills—Epirubicin—liver cancer	0.000414	0.00169	CcSEcCtD
Modafinil—Arrhythmia—Epirubicin—liver cancer	0.000412	0.00169	CcSEcCtD
Modafinil—Visual impairment—Doxorubicin—liver cancer	0.000411	0.00168	CcSEcCtD
Modafinil—Cinnarizine—CYP1A1—liver cancer	0.000408	0.101	CrCbGaD
Modafinil—Mental disorder—Epirubicin—liver cancer	0.000404	0.00165	CcSEcCtD
Modafinil—Erythema multiforme—Doxorubicin—liver cancer	0.000404	0.00165	CcSEcCtD
Modafinil—Malnutrition—Epirubicin—liver cancer	0.000402	0.00164	CcSEcCtD
Modafinil—Cardiac disorder—Doxorubicin—liver cancer	0.000396	0.00162	CcSEcCtD
Modafinil—Flatulence—Epirubicin—liver cancer	0.000396	0.00162	CcSEcCtD
Modafinil—Tension—Epirubicin—liver cancer	0.000394	0.00161	CcSEcCtD
Modafinil—Dysgeusia—Epirubicin—liver cancer	0.000393	0.00161	CcSEcCtD
Modafinil—Nervousness—Epirubicin—liver cancer	0.00039	0.0016	CcSEcCtD
Modafinil—Back pain—Epirubicin—liver cancer	0.000388	0.00159	CcSEcCtD
Modafinil—Angiopathy—Doxorubicin—liver cancer	0.000387	0.00159	CcSEcCtD
Modafinil—Muscle spasms—Epirubicin—liver cancer	0.000386	0.00158	CcSEcCtD
Modafinil—Immune system disorder—Doxorubicin—liver cancer	0.000385	0.00158	CcSEcCtD
Modafinil—Mediastinal disorder—Doxorubicin—liver cancer	0.000385	0.00157	CcSEcCtD
Modafinil—Chills—Doxorubicin—liver cancer	0.000383	0.00157	CcSEcCtD
Modafinil—Arrhythmia—Doxorubicin—liver cancer	0.000381	0.00156	CcSEcCtD
Modafinil—Fenoprofen—ALB—liver cancer	0.000375	0.0925	CrCbGaD
Modafinil—Mental disorder—Doxorubicin—liver cancer	0.000374	0.00153	CcSEcCtD
Modafinil—Ill-defined disorder—Epirubicin—liver cancer	0.000373	0.00153	CcSEcCtD
Modafinil—Malnutrition—Doxorubicin—liver cancer	0.000372	0.00152	CcSEcCtD
Modafinil—Anaemia—Epirubicin—liver cancer	0.000371	0.00152	CcSEcCtD
Modafinil—Agitation—Epirubicin—liver cancer	0.000369	0.00151	CcSEcCtD
Modafinil—Flatulence—Doxorubicin—liver cancer	0.000366	0.0015	CcSEcCtD
Modafinil—Tension—Doxorubicin—liver cancer	0.000365	0.00149	CcSEcCtD
Modafinil—Dysgeusia—Doxorubicin—liver cancer	0.000364	0.00149	CcSEcCtD
Modafinil—Malaise—Epirubicin—liver cancer	0.000362	0.00148	CcSEcCtD
Modafinil—Nervousness—Doxorubicin—liver cancer	0.000361	0.00148	CcSEcCtD
Modafinil—Vertigo—Epirubicin—liver cancer	0.000361	0.00148	CcSEcCtD
Modafinil—Syncope—Epirubicin—liver cancer	0.00036	0.00147	CcSEcCtD
Modafinil—Back pain—Doxorubicin—liver cancer	0.000359	0.00147	CcSEcCtD
Modafinil—Muscle spasms—Doxorubicin—liver cancer	0.000357	0.00146	CcSEcCtD
Modafinil—Palpitations—Epirubicin—liver cancer	0.000355	0.00145	CcSEcCtD
Modafinil—Loss of consciousness—Epirubicin—liver cancer	0.000353	0.00144	CcSEcCtD
Modafinil—Cough—Epirubicin—liver cancer	0.00035	0.00143	CcSEcCtD
Modafinil—Convulsion—Epirubicin—liver cancer	0.000348	0.00142	CcSEcCtD
Modafinil—Hypertension—Epirubicin—liver cancer	0.000347	0.00142	CcSEcCtD
Modafinil—Ill-defined disorder—Doxorubicin—liver cancer	0.000345	0.00141	CcSEcCtD
Modafinil—Anaemia—Doxorubicin—liver cancer	0.000343	0.00141	CcSEcCtD
Modafinil—Myalgia—Epirubicin—liver cancer	0.000342	0.0014	CcSEcCtD
Modafinil—Arthralgia—Epirubicin—liver cancer	0.000342	0.0014	CcSEcCtD
Modafinil—Chest pain—Epirubicin—liver cancer	0.000342	0.0014	CcSEcCtD
Modafinil—Agitation—Doxorubicin—liver cancer	0.000341	0.0014	CcSEcCtD
Modafinil—Anxiety—Epirubicin—liver cancer	0.000341	0.00139	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000339	0.00139	CcSEcCtD
Modafinil—Discomfort—Epirubicin—liver cancer	0.000338	0.00138	CcSEcCtD
Modafinil—Malaise—Doxorubicin—liver cancer	0.000335	0.00137	CcSEcCtD
Modafinil—Dry mouth—Epirubicin—liver cancer	0.000334	0.00137	CcSEcCtD
Modafinil—Vertigo—Doxorubicin—liver cancer	0.000334	0.00137	CcSEcCtD
Modafinil—Syncope—Doxorubicin—liver cancer	0.000333	0.00136	CcSEcCtD
Modafinil—Confusional state—Epirubicin—liver cancer	0.00033	0.00135	CcSEcCtD
Modafinil—Palpitations—Doxorubicin—liver cancer	0.000328	0.00134	CcSEcCtD
Modafinil—Anaphylactic shock—Epirubicin—liver cancer	0.000328	0.00134	CcSEcCtD
Modafinil—Oedema—Epirubicin—liver cancer	0.000328	0.00134	CcSEcCtD
Modafinil—Loss of consciousness—Doxorubicin—liver cancer	0.000327	0.00134	CcSEcCtD
Modafinil—Infection—Epirubicin—liver cancer	0.000326	0.00133	CcSEcCtD
Modafinil—Cough—Doxorubicin—liver cancer	0.000324	0.00133	CcSEcCtD
Modafinil—Phenprocoumon—ALB—liver cancer	0.000324	0.0797	CrCbGaD
Modafinil—Shock—Epirubicin—liver cancer	0.000322	0.00132	CcSEcCtD
Modafinil—Convulsion—Doxorubicin—liver cancer	0.000322	0.00132	CcSEcCtD
Modafinil—Nervous system disorder—Epirubicin—liver cancer	0.000321	0.00132	CcSEcCtD
Modafinil—Hypertension—Doxorubicin—liver cancer	0.000321	0.00131	CcSEcCtD
Modafinil—Tachycardia—Epirubicin—liver cancer	0.00032	0.00131	CcSEcCtD
Modafinil—Skin disorder—Epirubicin—liver cancer	0.000318	0.0013	CcSEcCtD
Modafinil—Hyperhidrosis—Epirubicin—liver cancer	0.000317	0.0013	CcSEcCtD
Modafinil—Myalgia—Doxorubicin—liver cancer	0.000316	0.00129	CcSEcCtD
Modafinil—Chest pain—Doxorubicin—liver cancer	0.000316	0.00129	CcSEcCtD
Modafinil—Arthralgia—Doxorubicin—liver cancer	0.000316	0.00129	CcSEcCtD
Modafinil—Anxiety—Doxorubicin—liver cancer	0.000315	0.00129	CcSEcCtD
Modafinil—Oxcarbazepine—ALB—liver cancer	0.000315	0.0776	CrCbGaD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000314	0.00129	CcSEcCtD
Modafinil—Discomfort—Doxorubicin—liver cancer	0.000312	0.00128	CcSEcCtD
Modafinil—Anorexia—Epirubicin—liver cancer	0.000312	0.00128	CcSEcCtD
Modafinil—Dry mouth—Doxorubicin—liver cancer	0.000309	0.00127	CcSEcCtD
Modafinil—Hypotension—Epirubicin—liver cancer	0.000306	0.00125	CcSEcCtD
Modafinil—Confusional state—Doxorubicin—liver cancer	0.000306	0.00125	CcSEcCtD
Modafinil—Anaphylactic shock—Doxorubicin—liver cancer	0.000303	0.00124	CcSEcCtD
Modafinil—Oedema—Doxorubicin—liver cancer	0.000303	0.00124	CcSEcCtD
Modafinil—Infection—Doxorubicin—liver cancer	0.000301	0.00123	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000299	0.00122	CcSEcCtD
Modafinil—Shock—Doxorubicin—liver cancer	0.000298	0.00122	CcSEcCtD
Modafinil—Nervous system disorder—Doxorubicin—liver cancer	0.000297	0.00122	CcSEcCtD
Modafinil—Insomnia—Epirubicin—liver cancer	0.000296	0.00121	CcSEcCtD
Modafinil—Tachycardia—Doxorubicin—liver cancer	0.000296	0.00121	CcSEcCtD
Modafinil—Skin disorder—Doxorubicin—liver cancer	0.000295	0.00121	CcSEcCtD
Modafinil—Paraesthesia—Epirubicin—liver cancer	0.000294	0.0012	CcSEcCtD
Modafinil—Hyperhidrosis—Doxorubicin—liver cancer	0.000293	0.0012	CcSEcCtD
Modafinil—Dyspnoea—Epirubicin—liver cancer	0.000292	0.0012	CcSEcCtD
Modafinil—Somnolence—Epirubicin—liver cancer	0.000291	0.00119	CcSEcCtD
Modafinil—Anorexia—Doxorubicin—liver cancer	0.000289	0.00118	CcSEcCtD
Modafinil—Dyspepsia—Epirubicin—liver cancer	0.000288	0.00118	CcSEcCtD
Modafinil—Warfarin—ALB—liver cancer	0.000287	0.0707	CrCbGaD
Modafinil—Decreased appetite—Epirubicin—liver cancer	0.000285	0.00117	CcSEcCtD
Modafinil—Hypotension—Doxorubicin—liver cancer	0.000283	0.00116	CcSEcCtD
Modafinil—Gastrointestinal disorder—Epirubicin—liver cancer	0.000283	0.00116	CcSEcCtD
Modafinil—Fatigue—Epirubicin—liver cancer	0.000283	0.00116	CcSEcCtD
Modafinil—Orphenadrine—CYP2E1—liver cancer	0.000281	0.0693	CrCbGaD
Modafinil—Pain—Epirubicin—liver cancer	0.00028	0.00115	CcSEcCtD
Modafinil—Constipation—Epirubicin—liver cancer	0.00028	0.00115	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000276	0.00113	CcSEcCtD
Modafinil—Insomnia—Doxorubicin—liver cancer	0.000274	0.00112	CcSEcCtD
Modafinil—Paraesthesia—Doxorubicin—liver cancer	0.000272	0.00111	CcSEcCtD
Modafinil—Dyspnoea—Doxorubicin—liver cancer	0.00027	0.00111	CcSEcCtD
Modafinil—Feeling abnormal—Epirubicin—liver cancer	0.00027	0.00111	CcSEcCtD
Modafinil—Somnolence—Doxorubicin—liver cancer	0.00027	0.0011	CcSEcCtD
Modafinil—Gastrointestinal pain—Epirubicin—liver cancer	0.000268	0.0011	CcSEcCtD
Modafinil—Dyspepsia—Doxorubicin—liver cancer	0.000267	0.00109	CcSEcCtD
Modafinil—Decreased appetite—Doxorubicin—liver cancer	0.000264	0.00108	CcSEcCtD
Modafinil—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000262	0.00107	CcSEcCtD
Modafinil—Fatigue—Doxorubicin—liver cancer	0.000261	0.00107	CcSEcCtD
Modafinil—Urticaria—Epirubicin—liver cancer	0.00026	0.00107	CcSEcCtD
Modafinil—Pain—Doxorubicin—liver cancer	0.000259	0.00106	CcSEcCtD
Modafinil—Constipation—Doxorubicin—liver cancer	0.000259	0.00106	CcSEcCtD
Modafinil—Abdominal pain—Epirubicin—liver cancer	0.000259	0.00106	CcSEcCtD
Modafinil—Body temperature increased—Epirubicin—liver cancer	0.000259	0.00106	CcSEcCtD
Modafinil—Feeling abnormal—Doxorubicin—liver cancer	0.00025	0.00102	CcSEcCtD
Modafinil—Gastrointestinal pain—Doxorubicin—liver cancer	0.000248	0.00102	CcSEcCtD
Modafinil—Hypersensitivity—Epirubicin—liver cancer	0.000241	0.000988	CcSEcCtD
Modafinil—Urticaria—Doxorubicin—liver cancer	0.000241	0.000986	CcSEcCtD
Modafinil—Abdominal pain—Doxorubicin—liver cancer	0.00024	0.000981	CcSEcCtD
Modafinil—Body temperature increased—Doxorubicin—liver cancer	0.00024	0.000981	CcSEcCtD
Modafinil—Asthenia—Epirubicin—liver cancer	0.000235	0.000963	CcSEcCtD
Modafinil—Pruritus—Epirubicin—liver cancer	0.000232	0.000949	CcSEcCtD
Modafinil—Diarrhoea—Epirubicin—liver cancer	0.000224	0.000918	CcSEcCtD
Modafinil—Hypersensitivity—Doxorubicin—liver cancer	0.000223	0.000915	CcSEcCtD
Modafinil—Ketoprofen—ALB—liver cancer	0.000221	0.0546	CrCbGaD
Modafinil—Asthenia—Doxorubicin—liver cancer	0.000218	0.000891	CcSEcCtD
Modafinil—Dizziness—Epirubicin—liver cancer	0.000217	0.000887	CcSEcCtD
Modafinil—Pruritus—Doxorubicin—liver cancer	0.000215	0.000878	CcSEcCtD
Modafinil—Phenytoin—ALB—liver cancer	0.000208	0.0514	CrCbGaD
Modafinil—Vomiting—Epirubicin—liver cancer	0.000208	0.000853	CcSEcCtD
Modafinil—Diarrhoea—Doxorubicin—liver cancer	0.000207	0.000849	CcSEcCtD
Modafinil—Rash—Epirubicin—liver cancer	0.000207	0.000846	CcSEcCtD
Modafinil—Dermatitis—Epirubicin—liver cancer	0.000206	0.000845	CcSEcCtD
Modafinil—Headache—Epirubicin—liver cancer	0.000205	0.00084	CcSEcCtD
Modafinil—Dizziness—Doxorubicin—liver cancer	0.0002	0.000821	CcSEcCtD
Modafinil—Nausea—Epirubicin—liver cancer	0.000195	0.000797	CcSEcCtD
Modafinil—Vomiting—Doxorubicin—liver cancer	0.000193	0.000789	CcSEcCtD
Modafinil—Rash—Doxorubicin—liver cancer	0.000191	0.000783	CcSEcCtD
Modafinil—Dermatitis—Doxorubicin—liver cancer	0.000191	0.000782	CcSEcCtD
Modafinil—Headache—Doxorubicin—liver cancer	0.00019	0.000778	CcSEcCtD
Modafinil—Nausea—Doxorubicin—liver cancer	0.00018	0.000737	CcSEcCtD
Modafinil—CYP2C19—Metabolism—NR1H4—liver cancer	4.41e-05	0.000275	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CRABP1—liver cancer	4.36e-05	0.000272	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CSF2—liver cancer	4.36e-05	0.000272	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTA3—liver cancer	4.33e-05	0.00027	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—EPT1—liver cancer	4.27e-05	0.000266	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GLUL—liver cancer	4.17e-05	0.00026	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CPT1B—liver cancer	4.17e-05	0.00026	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TAT—liver cancer	4.04e-05	0.000252	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NR1H4—liver cancer	4.02e-05	0.000251	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ADAM17—liver cancer	3.99e-05	0.000249	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTA4—liver cancer	3.96e-05	0.000247	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTA3—liver cancer	3.95e-05	0.000247	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—HPGDS—liver cancer	3.9e-05	0.000243	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.87e-05	0.000242	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTA2—liver cancer	3.86e-05	0.000241	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.86e-05	0.000241	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—HPGDS—liver cancer	3.81e-05	0.000238	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—F2—liver cancer	3.76e-05	0.000235	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PSMA4—liver cancer	3.75e-05	0.000234	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PSMD10—liver cancer	3.75e-05	0.000234	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTA1—liver cancer	3.73e-05	0.000233	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NAT2—liver cancer	3.68e-05	0.00023	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTA4—liver cancer	3.61e-05	0.000226	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CG—liver cancer	3.6e-05	0.000225	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GLUL—liver cancer	3.56e-05	0.000222	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CPT1B—liver cancer	3.56e-05	0.000222	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.54e-05	0.000221	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALDOB—liver cancer	3.53e-05	0.00022	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.53e-05	0.00022	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTA2—liver cancer	3.52e-05	0.00022	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PSMA4—liver cancer	3.47e-05	0.000217	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PSMD10—liver cancer	3.47e-05	0.000217	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NR1H4—liver cancer	3.43e-05	0.000214	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—F2—liver cancer	3.42e-05	0.000213	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTA1—liver cancer	3.4e-05	0.000212	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PSMD10—liver cancer	3.4e-05	0.000212	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PSMA4—liver cancer	3.4e-05	0.000212	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GOT2—liver cancer	3.38e-05	0.000211	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTA3—liver cancer	3.38e-05	0.000211	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CRABP1—liver cancer	3.37e-05	0.00021	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NAT2—liver cancer	3.36e-05	0.00021	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GOT2—liver cancer	3.3e-05	0.000206	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CG—liver cancer	3.27e-05	0.000204	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.23e-05	0.000202	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALDOB—liver cancer	3.22e-05	0.000201	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP2E1—liver cancer	3.18e-05	0.000198	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CD—liver cancer	3.17e-05	0.000198	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP2E1—liver cancer	3.11e-05	0.000194	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTA4—liver cancer	3.09e-05	0.000193	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CRABP1—liver cancer	3.07e-05	0.000192	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.03e-05	0.000189	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.02e-05	0.000188	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTA2—liver cancer	3.01e-05	0.000188	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYCS—liver cancer	2.97e-05	0.000186	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—HPGDS—liver cancer	2.95e-05	0.000184	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.93e-05	0.000183	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GGT1—liver cancer	2.92e-05	0.000182	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GOT1—liver cancer	2.92e-05	0.000182	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PRKCE—liver cancer	2.91e-05	0.000182	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYCS—liver cancer	2.91e-05	0.000181	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTA1—liver cancer	2.9e-05	0.000181	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CD—liver cancer	2.88e-05	0.000179	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NAT2—liver cancer	2.87e-05	0.000179	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GGT1—liver cancer	2.85e-05	0.000178	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GOT1—liver cancer	2.85e-05	0.000178	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.77e-05	0.000173	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.76e-05	0.000172	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CB—liver cancer	2.76e-05	0.000172	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IGF2—liver cancer	2.76e-05	0.000172	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALDOB—liver cancer	2.75e-05	0.000172	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CPT1B—liver cancer	2.75e-05	0.000172	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GLUL—liver cancer	2.75e-05	0.000172	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HPGDS—liver cancer	2.69e-05	0.000168	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.67e-05	0.000167	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.67e-05	0.000166	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NR1H4—liver cancer	2.65e-05	0.000165	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.63e-05	0.000164	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CRABP1—liver cancer	2.63e-05	0.000164	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PSMA4—liver cancer	2.63e-05	0.000164	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PSMD10—liver cancer	2.63e-05	0.000164	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTP1—liver cancer	2.62e-05	0.000164	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTA3—liver cancer	2.61e-05	0.000163	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—HMOX1—liver cancer	2.58e-05	0.000161	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CSF2—liver cancer	2.57e-05	0.000161	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—RAF1—liver cancer	2.57e-05	0.00016	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTP1—liver cancer	2.56e-05	0.00016	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GOT2—liver cancer	2.55e-05	0.000159	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—H2AFX—liver cancer	2.54e-05	0.000158	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—IL2—liver cancer	2.54e-05	0.000158	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—HMOX1—liver cancer	2.53e-05	0.000158	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CB—liver cancer	2.51e-05	0.000156	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.43e-05	0.000152	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTM1—liver cancer	2.41e-05	0.00015	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP2E1—liver cancer	2.4e-05	0.00015	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.4e-05	0.00015	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PSMD10—liver cancer	2.39e-05	0.000149	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PSMA4—liver cancer	2.39e-05	0.000149	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTA4—liver cancer	2.38e-05	0.000149	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.36e-05	0.000148	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTM1—liver cancer	2.35e-05	0.000147	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GOT2—liver cancer	2.33e-05	0.000145	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.33e-05	0.000145	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTA2—liver cancer	2.32e-05	0.000145	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL2—liver cancer	2.3e-05	0.000144	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HPGDS—liver cancer	2.3e-05	0.000143	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TERT—liver cancer	2.29e-05	0.000143	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP1A1—liver cancer	2.28e-05	0.000142	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.28e-05	0.000142	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYCS—liver cancer	2.25e-05	0.00014	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTA1—liver cancer	2.24e-05	0.00014	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP1A1—liver cancer	2.23e-05	0.000139	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NAT2—liver cancer	2.22e-05	0.000138	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GGT1—liver cancer	2.2e-05	0.000138	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GOT1—liver cancer	2.2e-05	0.000138	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP2E1—liver cancer	2.19e-05	0.000137	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—MTHFR—liver cancer	2.13e-05	0.000133	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALDOB—liver cancer	2.12e-05	0.000133	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.12e-05	0.000132	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KDR—liver cancer	2.1e-05	0.000131	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PPARA—liver cancer	2.09e-05	0.00013	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK14—liver cancer	2.08e-05	0.00013	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—MTHFR—liver cancer	2.08e-05	0.00013	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.08e-05	0.00013	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.05e-05	0.000128	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYCS—liver cancer	2.05e-05	0.000128	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PSMA4—liver cancer	2.05e-05	0.000128	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PSMD10—liver cancer	2.05e-05	0.000128	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ESR1—liver cancer	2.04e-05	0.000128	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PPARA—liver cancer	2.04e-05	0.000127	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CRABP1—liver cancer	2.03e-05	0.000126	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—F2—liver cancer	2.02e-05	0.000126	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GGT1—liver cancer	2.01e-05	0.000125	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GOT1—liver cancer	2.01e-05	0.000125	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GOT2—liver cancer	1.99e-05	0.000124	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTP1—liver cancer	1.98e-05	0.000124	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—HMOX1—liver cancer	1.95e-05	0.000122	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CG—liver cancer	1.93e-05	0.000121	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APC—liver cancer	1.93e-05	0.000121	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2E1—liver cancer	1.87e-05	0.000117	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTM1—liver cancer	1.82e-05	0.000114	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—BRAF—liver cancer	1.82e-05	0.000113	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.81e-05	0.000113	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTP1—liver cancer	1.81e-05	0.000113	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CG—liver cancer	1.79e-05	0.000112	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HMOX1—liver cancer	1.78e-05	0.000111	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HPGDS—liver cancer	1.77e-05	0.000111	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYCS—liver cancer	1.75e-05	0.000109	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CG—liver cancer	1.75e-05	0.000109	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PPARG—liver cancer	1.73e-05	0.000108	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP1A1—liver cancer	1.73e-05	0.000108	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GGT1—liver cancer	1.72e-05	0.000107	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GOT1—liver cancer	1.72e-05	0.000107	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CD—liver cancer	1.7e-05	0.000106	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PPARG—liver cancer	1.69e-05	0.000105	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CA—liver cancer	1.68e-05	0.000105	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SERPINE1—liver cancer	1.68e-05	0.000105	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—KRAS—liver cancer	1.66e-05	0.000104	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTM1—liver cancer	1.66e-05	0.000104	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—MTHFR—liver cancer	1.61e-05	0.0001	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PSMA4—liver cancer	1.58e-05	9.85e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PSMD10—liver cancer	1.58e-05	9.85e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPARA—liver cancer	1.58e-05	9.85e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1A1—liver cancer	1.57e-05	9.82e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CD—liver cancer	1.57e-05	9.81e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ALB—liver cancer	1.55e-05	9.69e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTP1—liver cancer	1.54e-05	9.63e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CD—liver cancer	1.54e-05	9.59e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GOT2—liver cancer	1.54e-05	9.59e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CA—liver cancer	1.53e-05	9.54e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HMOX1—liver cancer	1.52e-05	9.5e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ALB—liver cancer	1.52e-05	9.47e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RAF1—liver cancer	1.52e-05	9.47e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CB—liver cancer	1.48e-05	9.24e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MTOR—liver cancer	1.48e-05	9.24e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—MTHFR—liver cancer	1.47e-05	9.15e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2E1—liver cancer	1.44e-05	9.01e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPARA—liver cancer	1.44e-05	8.98e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTM1—liver cancer	1.42e-05	8.85e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.42e-05	8.85e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—HRAS—liver cancer	1.41e-05	8.82e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN1B—liver cancer	1.39e-05	8.67e-05	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—AKT1—liver cancer	1.37e-05	8.58e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CB—liver cancer	1.37e-05	8.55e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CASP3—liver cancer	1.36e-05	8.5e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL2—liver cancer	1.36e-05	8.49e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6—liver cancer	1.35e-05	8.45e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CG—liver cancer	1.35e-05	8.43e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYCS—liver cancer	1.35e-05	8.43e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP1A1—liver cancer	1.34e-05	8.39e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CB—liver cancer	1.34e-05	8.36e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GOT1—liver cancer	1.33e-05	8.27e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GGT1—liver cancer	1.33e-05	8.27e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCND1—liver cancer	1.33e-05	8.27e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—JUN—liver cancer	1.32e-05	8.26e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CTNNB1—liver cancer	1.31e-05	8.19e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPARG—liver cancer	1.3e-05	8.14e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.29e-05	8.07e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP9—liver cancer	1.29e-05	8.03e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN1A—liver cancer	1.28e-05	8e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MTHFR—liver cancer	1.25e-05	7.82e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK8—liver cancer	1.25e-05	7.81e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—AKT1—liver cancer	1.25e-05	7.79e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CG—liver cancer	1.23e-05	7.69e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPARA—liver cancer	1.23e-05	7.67e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTP1—liver cancer	1.19e-05	7.43e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPARG—liver cancer	1.19e-05	7.42e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CD—liver cancer	1.19e-05	7.41e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HMOX1—liver cancer	1.17e-05	7.33e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALB—liver cancer	1.17e-05	7.32e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—liver cancer	1.16e-05	7.21e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—STAT3—liver cancer	1.14e-05	7.14e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.1e-05	6.89e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTM1—liver cancer	1.09e-05	6.83e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CD—liver cancer	1.08e-05	6.76e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALB—liver cancer	1.07e-05	6.67e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MYC—liver cancer	1.06e-05	6.64e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TGFB1—liver cancer	1.06e-05	6.62e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CG—liver cancer	1.05e-05	6.57e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1A1—liver cancer	1.04e-05	6.48e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CB—liver cancer	1.04e-05	6.46e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPARG—liver cancer	1.02e-05	6.34e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KRAS—liver cancer	9.83e-06	6.13e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MTHFR—liver cancer	9.67e-06	6.04e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPARA—liver cancer	9.49e-06	5.92e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CB—liver cancer	9.44e-06	5.89e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CD—liver cancer	9.26e-06	5.78e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALB—liver cancer	9.14e-06	5.7e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CA—liver cancer	9.03e-06	5.63e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TP53—liver cancer	8.73e-06	5.45e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CA—liver cancer	8.35e-06	5.21e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HRAS—liver cancer	8.35e-06	5.21e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CA—liver cancer	8.16e-06	5.1e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CG—liver cancer	8.13e-06	5.07e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CB—liver cancer	8.07e-06	5.04e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6—liver cancer	7.99e-06	4.99e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPARG—liver cancer	7.84e-06	4.89e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT1—liver cancer	7.37e-06	4.6e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CD—liver cancer	7.14e-06	4.46e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALB—liver cancer	7.05e-06	4.4e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AKT1—liver cancer	6.82e-06	4.26e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AKT1—liver cancer	6.67e-06	4.16e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CA—liver cancer	6.31e-06	3.94e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CB—liver cancer	6.23e-06	3.89e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CA—liver cancer	5.76e-06	3.59e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKT1—liver cancer	5.16e-06	3.22e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CA—liver cancer	4.92e-06	3.07e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKT1—liver cancer	4.7e-06	2.93e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKT1—liver cancer	4.02e-06	2.51e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CA—liver cancer	3.8e-06	2.37e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKT1—liver cancer	3.1e-06	1.94e-05	CbGpPWpGaD
